Stability of extemporaneously prepared cytarabine, methotrexate sodium, and methylprednisolone sodium succinate
- PMID: 22261946
- DOI: 10.2146/ajhp110208
Stability of extemporaneously prepared cytarabine, methotrexate sodium, and methylprednisolone sodium succinate
Erratum in
- Am J Health Syst Pharm. 2012 Jul 1;69(13):1102. Dosage error in article text
Abstract
Purpose: The short-term stability of extemporaneously prepared triple intrathecal therapy, containing cytarabine, methotrexate sodium, and methylprednisolone sodium succinate, was evaluated.
Methods: Three batches of triple intrathecal solution were prepared using commercially available products and stored in three different packaging materials (plastic syringe system, brown glass vials, and brown glass vials filled with metal needles). The solutions were protected from light and stored at 5 °C, 25 °C, and 40 °C or exposed to ultraviolet and visible light at 25 °C, compliant with the International Conference on Harmonisation. Samples were taken immediately before and after 4, 8, 24, 32, and 48 hours of storage. Simultaneous high-performance liquid chromatography- ultraviolet light/diode array detector assay of cytarabine, methotrexate sodium, and methylprednisolone sodium succinate was performed using a fused-core stationary phase and an acetonitrile-based gradient. First-order kinetic degradation values were calculated, and temperature dependence was evaluated using the Arrhenius equation.
Results: Cytarabine was stable under all storage conditions. Methotrexate sodium displayed significant degradation after light exposure but remained stable under the other storage conditions. Methylprednisolone sodium succinate was found to be the most labile component in the triple intrathecal solution. Temperature-dependent degradation was observed, resulting in 46% degradation after 48 hours at 40 °C. Two degradants were formed: methylprednisolone and methylprednisolone hydrogen succinate. Packaging material and batch-to-batch variability did not significantly influence the stability of the triple intrathecal solution.
Conclusion: Triple intrathecal solution of cytarabine, methotrexate sodium, and methylprednisolone sodium succinate was stable for up to 12 hours when stored at 5 °C and protected from light.
Similar articles
-
Stability of a standardized preparation of methotrexate, cytarabine, and methylprednisolone hemisuccinate for intrathecal use.J Oncol Pharm Pract. 2022 Jul 26:10781552221117228. doi: 10.1177/10781552221117228. Online ahead of print. J Oncol Pharm Pract. 2022. PMID: 35892160
-
Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures.Am J Hosp Pharm. 1984 Sep;41(9):1802-6. Am J Hosp Pharm. 1984. PMID: 6496516
-
Doxofylline and methylprednisolone sodium succinate are stable and compatible under normal injection conditions.Pak J Pharm Sci. 2013 Mar;26(2):261-5. Pak J Pharm Sci. 2013. PMID: 23455194
-
Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.J Oncol Pharm Pract. 2009 Mar;15(1):45-52. doi: 10.1177/1078155208096902. Epub 2008 Sep 4. J Oncol Pharm Pract. 2009. PMID: 18772215 Review.
-
Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.Cancer Chemother Pharmacol. 1986;17(1):1-10. doi: 10.1007/BF00299858. Cancer Chemother Pharmacol. 1986. PMID: 2421936 Review.
Cited by
-
A critical quality parameter in quantitative fused-core chromatography: The injection volume.J Pharm Anal. 2013 Oct;3(5):330-334. doi: 10.1016/j.jpha.2013.02.002. Epub 2013 Feb 17. J Pharm Anal. 2013. PMID: 29403835 Free PMC article.
-
Clinical Efficacy of Retroauricular Injection of Methylprednisolone Sodium Succinate in the Treatment of Sudden Deafness with Type 2 Diabetes.Comput Math Methods Med. 2022 Jul 22;2022:3097436. doi: 10.1155/2022/3097436. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Sep 27;2023:9759346. doi: 10.1155/2023/9759346. PMID: 35912152 Free PMC article. Retracted.
-
Compatibility and stability of methylprednisolone sodium succinate and granisetron hydrochloride in 0.9% sodium chloride solution.Medicine (Baltimore). 2022 Jul 15;101(28):e29674. doi: 10.1097/MD.0000000000029674. Medicine (Baltimore). 2022. PMID: 35839031 Free PMC article.
-
Reversed-phase fused-core HPLC modeling of peptides.J Pharm Anal. 2013 Apr;3(2):93-101. doi: 10.1016/j.jpha.2012.11.002. Epub 2012 Nov 30. J Pharm Anal. 2013. PMID: 29403802 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources